Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02130089
Other study ID # 13-186
Secondary ID
Status Completed
Phase N/A
First received April 28, 2014
Last updated January 26, 2016
Start date April 2014
Est. completion date November 2015

Study information

Verified date January 2016
Source Academy of Nutrition and Dietetics
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardNew Zealand: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this project is to understand if more frequent education of dialysis patients (patients with kidney failure who get their blood cleaned and fluid removed by a machine instead of their kidneys) on reducing sodium intake reduces the amount of fluid weight that patients gain between dialysis sessions. Patients who usually gain more fluid than is considered ideal will be recruited for this project. Because all patients gain different amounts to start, data will be collected for 3 months while the patients receive their usual amount of dietitian education. Then the patients will receive intensive (2x/month) education on reducing sodium intake from the dietitian and the same data will be collected to see if they gain less after the education. After 3 months of intensive education, data will be collected for one more month to see if patients keep gaining less or if they go back to their old patterns.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Average Interdialytic weight gain (IDWG) for 2 weeks prior to screening period greater than or equal to 4% estimated dry weight

- Able to sign the locally approved informed consent

- Willing to receive dietitian education on sodium and fluid control during normal dialysis time

- Receiving thrice weekly maintenance hemodialysis for greater than or equal to 6 months Age greater than or equal to 18 years

Exclusion Criteria:

- On hospice or international equivalent

- Receiving corticosteroid treatment

- Less than 18 years old

- On interdialytic parenteral nutrition

- Transfer to another facility expected within 3 months

- Severe malnutrition, as assessed by Subjective Global Assessment (SGA) or other standard assessment tool

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Intensive Tailored Education


Locations

Country Name City State
New Zealand Auckland Board of Health Auckland

Sponsors (1)

Lead Sponsor Collaborator
Academy of Nutrition and Dietetics

Country where clinical trial is conducted

New Zealand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average Percent Interdialytic Weight Gain monthly for 7 months No
Secondary Thirst Intensity will be measured by a 100 mm Visual Analog Scale. Patients are asked to mark the point on the VAS which represents their work thirst since the last dialysis. Zero is considered no thirst and 100 is extremely thirsty. This tool has been shown to correlate to the Thirst Distress tool developed by Welsh in 2002. monthly for 7 months No
Secondary Sodium and Fluid Knowledge Will be assessed using the sodium questions of the tool created by Kim (Korean J Nutr 2001), as modified by Park (J Ren Nutr 2008). Monthly for 4 months No
See also
  Status Clinical Trial Phase
Completed NCT04534114 - Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug Phase 2